Accesso libero

Clinical relevance of the borderline results of the Hybrid Capture 2 High-Risk HPV DNA assay with cervical samples collected in Specimen Transport Medium

INFORMAZIONI SU QUESTO ARTICOLO

Cita

Jerneja Varl
Department of Experimental Oncology, Institute of Oncology LjubljanaLjubljana, Slovenia
University of Ljubljana, Faculty of MedicineLjubljana, Slovenia
Urska Ivanus
ZORA National Cervical Cancer Screening Programme, Epidemiology and Cancer Registry, Institute of Oncology LjubljanaLjubljana, Slovenia
Ziva Pohar Marinsek
Department of Cytopathology, Institute of Oncology LjubljanaLjubljana, Slovenia
Tine Jerman
ZORA National Cervical Cancer Screening Programme, Epidemiology and Cancer Registry, Institute of Oncology LjubljanaLjubljana, Slovenia
Anja Ostrbenk Valencak
Institute of Microbiology and Immunology, Faculty of Medicine, University of LjubljanaLjubljana, Slovenia
Mario Poljak
Institute of Microbiology and Immunology, Faculty of Medicine, University of LjubljanaLjubljana, Slovenia
Veronika Kloboves Prevodnik
Department of Cytopathology, Institute of Oncology LjubljanaLjubljana, Slovenia
eISSN:
1581-3207
Lingua:
Inglese
Frequenza di pubblicazione:
4 volte all'anno
Argomenti della rivista:
Medicine, Clinical Medicine, Internal Medicine, Haematology, Oncology, Radiology